Phoenix—A new evidence-based algorithm can assist providers in determining the proper management of central venous access devices (CVADs) and, thereby, potentially better address or prevent any resulting skin damage in their patients. The tool was described at a session at the National Home Infusion Association 2018 Annual Conference.
Skin impairment related to CVADs is an underrecognized complication, noted Daphne Broadhurst, RN,